Glaukos Corporation (GKOS) Reports Q3 EPS of $0.03

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Glaukos Corporation (GKOS) Reports Q3 EPS of $0.03

Glaukos Corporation Announces Third Quarter 2016 Financial Results

November 10, 2016 4:15 PM EST

Company Raises 2016 Net Sales Guidance

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced financial results for the third quarter ended September 30, 2016. Key highlights include:

Achieved 56% net sales growth to $29.6 million in the third quarter of 2016, compared to $19.0 million in the third quarter of 2015 Reported net income of $1.2 million, or $0.03 per... More